NewsMarkets

World

China Faces Scrutiny After Child Deaths in Fast-Track Gene Therapy Trials

Two children die from gene therapies, prompting calls for strengthened laws and faster disclosure of adverse events to protect public trust.

1 publisher · 3 articles · first seen 8 Sept 2026 · updated 50d ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

1 publisher has covered this in 3 articles since 8 Sept 2026. Nature published first, on 8 September at 00:00 UTC. The most recent article, from Nature, appeared on 8 September at 00:00 UTC.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. China’s fast-track clinical trials are in the spotlight after child deaths Nature ·
  2. Two children died from gene therapies in China: where the field goes next Nature ·
  3. Daily briefing: Gene-therapy deaths put spotlight on trials in China Nature ·

In this story

Embed this story

Paste this into any web page to show the live odds, with a link back here.